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among women between the ages of 15 and 44 has in-
creased slightly in the last three years (3).  Of all infer-
tile couples, 40-50% is attributed to female infertility (4). 
It is caused by many factors, and fallopian tube abnor-
malities cause about 30–35% of cases of female infertility 
(5).  
Imaging techniques, such as hysterosalpingography 
(HSG), play an important role in diagnostic work-up and 
treatment planning for infertile women (5). HSG provides 
an optimal depiction of the fallopian tubes, and is used to 
assess tubal patency because it has a sensitivity of 85% to 
100% in identifying tubal occlusion (3, 6). In this proce-
dure, the uterine and tubal cavities are visualized radio-
graphically through the transcervical injection of radio-
contrast dye (3). This invasive procedure is usually un-
comfortable and painful because cervical instrumentation, 
uterine distension with injection of the dye or peritoneal 
irritation secondary to contrast material spill, can lead to 
pain and discomfort during the procedure (1, 2). The main 
cause of pain experienced during HSG is secondary to the 
uterine distension with the dye resulting in the release of 
local prostaglandins, which stimulate uterine cramps. The 
pain is conducted through the pelvic splanchnic nerves 
from the cervix and lower part of the uterus, whereas pain 
from the fundus and body of the uterus is transmitted by 
the hypogastric nerves (7).  
Many different interventions have been evaluated for 
pain relief during and after HSG including oral, intrave-
nous, intrauterine and topical analgesics (3, 8-10). How-
ever, there is no agreement in regard to the optimal meth-
od for pain relief or timing of its administration. Also, it 
seems that there is no evidence about methods that relieve 
fallopian tubes spasm during HSG.  
Hyoscine N-Butyl Bromide (HBB) is an anti-spasmodic 
drug. It relieves spasms in the smooth muscle cells of the 
female genital tract, especially the cervico-uterine plexus 
(11). HBB blocks impulse transmission in parasympathet-
ic ganglia with the onset of action taking 30 minutes from 
intake (12). It has been ordinarily utilized for the relief of 
abdominal cramps during many procedures such as endos-
copy, renal colic, biliary colic etc. (13, 14). However, it 
seems that investigations of the potential benefit of HBB 
(20 mg I.M.) in HSG are scarce. Some studies were used 
with HBB administered orally in order to relieve the pain 
during HSG (2, 12) and intravenous HBB for relieving 
spasm during this procedure (15). There is no study that 
assesses the effect of intramuscular HBB on pain relief 
during and after HSG and tubal spasm during this proce-
dure. 
Since antispasmodic drugs are usually used for the relief 
of muscle spasms, our hypothesis was that an antispas-
modic drug such as HBB could decrease pain and fallopi-
an tube spasm during and after HSG by affecting uterine 
contractions.  
The primary objectives of this study were to evaluate 
the efficacy of intramuscular HBB on decreasing pain 
during and after the performance of HSG and also to eval-
uate the relief of fallopian tube spasm during HSG. The 
secondary objective included evaluation of the side effects 
of HSG in HBB and control groups. To meet these objec-
tives, we administered intramuscular HBB prior to HSG in 
infertile women in a radiology setting, measuring the pri-
mary and secondary outcomes of patients.  
 
Methods 
Design 
In this randomized single-blind controlled clinical trial, 
infertile women who referred to a radiology clinic affiliat-
ed to Arak University of Medical Sciences between July 
2017 and August 2017, were invited to participate in this 
study.  
According to a similar study (2), with an alpha error of 
0.05 and a statistical power of 80%, a sample size of at 
least 43 women in each group was calculated. Considering 
a possible 15% sample attrition rate, the required sample 
size was calculated as 50 patients in each group. 
 
2)21(
)()( 2221212/1
χχ
βα
−
++
=
−−
SSZZ
n  
 
Participants 
Patients were selected by convenience sampling and 
then were randomly assigned to HBB and control groups 
according to predesigned blocks with a block size of 4. In 
this type of randomization, there are six possible permuta-
tions with balanced group allocation. At first, the list of 
blocks was specified, and numbers 1 to 6 were assigned to 
these blocks. Then numbers 1 to 6 were randomly selected 
from a table of random numbers, and a sequence of A and 
B were formed. Participants were assigned to intervention 
(A) and control (B) groups according to the randomly 
selected block.    
One hundred women were assigned in the HBB group 
(n=50) and in the control group (n=50). They completed 
the HSG procedure and were evaluated for the outcome. 
Patients were blinded as to the assignments to interven-
tion. 
Women who had the inclusion criteria and were willing 
to be participants were included in this research. Inclusion 
criteria were infertile women, aged between 20–45 years 
old, who did not receive any analgesics in the 24 hour 
prior to HSG. Women who currently had anxiety and ma-
jor depression, a sexually transmitted disease (STD), pel-
vic inflammatory disease (PID) or abnormal uterine bleed-
ing, abnormal Pap smear, history of cervical surgery, uter-
us malignancies, hemodynamic instability during HSG, 
and contraindication or hypersensitivity to HBB were ex-
cluded. Before random allocation of the participants to 
HBB and control groups, sixteen women were excluded: 
three women had a history of cervical surgery, four wom-
en had irregular uterine bleeding and three women had 
received oral analgesics 24 hours prior to HSG. In addi-
tion, six women declined participation in the study (Fig. 
1). 
Since HSG is best scheduled for the period of 2-5 days 
immediately after the end of menses (3), all participants 
who were included in the study were appointed at this 
interval of their menstrual cycle. 
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Intervention 
Women in the HBB group received 20 mg/1cc HBB in-
tramuscularly (Manufactured in Iran by OSVEH Pharma 
Co.) 30 minutes before the procedure. Women in the con-
trol group did not receive any medication.  
All HSGs were performed by a single experienced radi-
ologist (F.S.) and one assisting midwife. Women lay in 
the lithotomy position and then the radiologist placed a 
sterile speculum into the vagina and after visualization of 
the cervix, it was cleaned with povidone-iodine. Then the 
anterior lip of the cervix was grasped with a tenaculum, 
and a sterile Rubin’s cannula was inserted into the cervical 
canal. A 5 ml water-soluble contrast dye (Iohexol; each ml 
contains: 518 mg Iohexol equivalent to 240 mg Iodine – 
Aburaihan Pharmaceutical Co; Tehran; Iran) was injected 
over 20 seconds into the uterine cavity.   
When the uterine cavity was fully filled with the dye, 
radiographic images were taken in the anteroposterior 
view. After checking the radiographic images, it was de-
termined whether another image should be prepared or 
not. The presence or absence of tubal spasm was deter-
mined in this stage according to the radiologic images.  
At the end of the procedure, all instruments were re-
moved and women were under observation in the radiolo-
gy clinic for 30 minutes. Women were offered mefenamic 
acid (250 mg), as an additional analgesic if needed, at 30 
minutes post-procedure. 
 
Measurements 
Baseline characteristics of these women were collected 
through a questionnaire (age, type, and duration of infer-
tility, history relating to dysmenorrhea, dyspareunia, pel-
 
Fig. 1. CONSORT flow diagram of participant enrollment, allocation, follow up and data analysis 
Lost to follow up (n=0) 
Discontinued intervention (n=0) 
Lost to follow up (n=0) 
 
Analysis 
Analyzed (n=50) 
- Excluded from analysis (n=0) 
Analyzed (n=50) 
- Excluded from analysis (n=0) 
- Pain evaluation by Numeric Analog Scale 
- Tubal spasm evaluation by checking the radiologic images 
- Side effects evaluation of the HSG procedure
Allocation 
Allocated to control group (n=50) 
 
Allocated to HBB group (n=50) 
- Received allocated intervention (n= 50) 
- Did not receive allocated intervention (n= 0) 
Follow up 
Assessed for eligibility(n=116) 
Randomized (n=100) 
Excluded (n=16): 
Not meeting inclusion criteria (n=10) 
Declined to participate (n=6) 
Enrollment 
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vic inflammatory disease, and previous delivery type) 
before the procedure.  
One of the primary outcomes was the patients' self-
reported pain on a 10-point Numeric Pain Rating Scale 
(NPRS) ranging from 0= no pain to10= maximum pain. 
Women were asked to rate the intensity of pain experi-
enced twice: immediately after injection of the dye, and 
30 minutes following the end of the procedure. The NPRS 
is a valid and reliable scale to measure pain intensity (16). 
High test–retest reliability has been observed for this scale 
(r=0.96) (17). For construct validity, the NPRS was shown 
to be highly correlated to the Visual Analog Scale (VAS) 
range from 0.86 to 0.95 (16). 
 Another primary outcome was the patients' tubal spasm 
that was determined according to the radiologic images. 
When the uterine cavity was filled with the dye, and radi-
ographic images were taken, presence or absence of tubal 
spasm was determined by a radiologist (F.S) in the clinic.  
In addition, secondary outcomes included patients' re-
sponse to questions about side effects of HSG. Nausea, 
vomiting, sweating, dizziness, bradycardia, and hypoten-
sion associated with the HSG were assessed after the pro-
cedure.  
 
Data Analysis 
Statistical analysis was performed using SPSS version 
18 (PASW Statistics 18, SPSS Inc, Chicago, IL). Descrip-
tive statistics are presented as mean and standard devia-
tion for quantitative variables and as frequency distribu-
tion for categorical variables. To ensure that the data were 
normally distributed, a Kolmogorov-Smirnov test (K-S 
test) was carried out. An independent sample t-test, chi-
square or Fisher’s exact tests were used to determine sta-
tistically significant differences when comparing the char-
acteristics of HBB and control groups. Because the pain 
score variable was not normally distributed, it was pre-
sented as median (p10, p90) and compared between two 
groups using Mann-Whitney test. Logistic regression 
analysis and ANCOVA were carried out to identify the 
effect of group on the tubal spasm (yes/no) and pain in the 
presence of demographic and clinical variables. p<0.05 
was considered as statistically significant.  
 
Ethical considerations 
This study received the registration number IRCT 
2017021132455N2 in the Iranian Registry of clinical tri-
als. The study was approved by the Ethics Committee of 
Vice Chancellor for Research, Arak University of Medical 
Sciences with the code of IR.ARAKMU.REC.1395.37. 
Information about this study was provided to all partici-
pants, and they signed the informed consent form. 
 
Results 
Mean age of the sample in the intervention group was 
(31.46±5.54) years and in the control group was 
(29.40±5.25) years. Also, mean duration of infertility in 
the intervention and control groups were (25.32±30.19) 
and (27.26±32.84) years, respectively. There was no sta-
tistically significant difference between the two groups 
related to the age (p=0.06, t=1.90) and duration of the 
infertility (p=0.44, t=1.47) at the beginning of the study. 
Also,    
there was no significant difference in baseline character-
istics between the two groups according to the type of 
infertility, history of dysmenorrhea, dyspareunia, pelvic 
inflammatory disease, and previous delivery type (p>0.05) 
(Table 1). 
 Although the women who received HBB recorded a 
slightly lower pain score both immediately after dye injec-
tion (p=0.29) and 30 minutes after the procedure (p=0.26), 
statistically significant differences were not observed be-
tween the HBB and the control groups. In comparing the 
pain score at the point of dye injection, the pain score is 
dramatically decreased 30 minutes after ending the HSG 
procedure in both groups (Table 2). 
During the HSG, 24% of those in the HBB group had 
Table 1. Characteristics of the HBB and control groups 
Variable Category Hyoscine-N-butyl bromide group 
(n=50) 
n (%) 
Control group 
(n=50) 
n (%) 
X2 p 
Type of infertility Primary 
Secondary 
30 (60) 
20 (40) 
30 (60) 
20 (40) 
2.09† 1 
History of dysmenorrhea Yes 
No 
23 (46) 
27 (54) 
18 (36) 
32 (64) 
 
1.03† 
 
0.41 
History of dyspareunia Yes 
No 
18 (36) 
32 (64) 
13 (26) 
37 (74) 
1.18† 0.38 
History of PID Yes 
No 
2 (4) 
48 (96) 
7 (14) 
43 (86) 
3.05† 0.16 
Previous delivery type Previous NVD 
Previous CS 
Nulliparous 
8 (16) 
12 (24) 
30 (60) 
11(22) 
9 (18) 
30 (60) 
0.90 0.63 
† Fisher exact test 
Abbreviations: NVD: Normal Vaginal Delivery; CS: Cesarean Section 
 
Table 2. Pain scores in HBB and the control groups 
NPRS* score results$  Hyoscine-N-butyl bromide group 
(n=50) 
Control group 
(n=50) 
p† 
Pain after dye injection 7 (4-10) 8 (3-10) 0.29 
Pain 30 min after HSG 1 (0-5) 1.5 (0-7) 0.26 
* Numeric Pain Rating Scale 
$ All results are presented as median [inter-percentile range] 
† Mann- Whitney test  
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tubal spasm, while in the control group this was 34%. 
However, the difference was not statistically significant 
between the two groups (p=0.37) (Table 3).  
Logistic regression analysis and ANCOVA showed that 
none of the demographic and clinical variables have any 
effect on the relationship between the treatment groups 
and spasm and pain during and after HSG. In other words, 
these variables were not predictors for spasm and pain 
experienced during and after HSG (Tables 4, 5, 6). 
The results revealed that there was no statistically sig-
nificant difference between the HBB and the control 
groups in terms of reported side effects of the HSG proce-
dure (p=0.52). Main reported side effects were nausea and 
dizziness that occurred in nineteen women in both of the 
two groups (Table 7). None of the women showed an al-
lergic response to the contrasting agent. All women were 
Table 3. Tubal spasm during HSG in the HBB and the control groups (n=100) 
Tubal spasm during HSG Hyoscine-N-butyl bromide group (n=50) Control group (n=50) p† 
   
n (%) n (%)  
Yes 12 (24) 17 (34) 0.37 
No 38 (76) 33 (66) 
Total 50 (100) 50 (100) 
† Fisher exact test 
 
Table 4. Results of the logistic regression in investigating of the effect of HBB on tubal spasm in the presence of demographic and clinical variables 
p OR (95% CI) Predictor variables 
0.181 9.320 Constant 
0.126 2.186 (0.802-5.957) Study groups (base=without Hyoscine) 
0.627 0.976 (0.886-1.076) Age 
0.215 0.991 (0.977-1.005) Infertility time 
0.832 1.193 (0.233-6.099) PID history (base=no) 
0.179 0.488 (0.171-1.390) Dysparonia (base=no) 
0.277 0.591 (0.299-1.524) Dysmenorrhea (base=no) 
  Delivery type (base=none) 
0.097 0.282 (0.063-1.259) NVD 
0.957 1.035 (0.297-3.614) C/S 
Dependent Variable: Tubal spasm 
 
Table 5. Results of the linear regression in investigating of the effect of HBB on pain during HSG in the presence of demographic and clinical varia-
bles 
p B (95% CI) Parameters 
0.000 8.589 (5.598-11.579) Intercept 
0.894 -0.073 (-1.160-1.014) Study groups  (base=without Hyoscine) 
0.350 -0.050 (-0.157-0.056) Age 
0.459 0.006 (-0.011-0.024) Infertility time 
0.333 0.899 (-0.937-2.736) PID history (base=no) 
0.984 0.012 (-1.163-1.186) Dysparonia (base=no)  
0.862 0.094 (-0.979-1.168) Dysmenorrhea (base=no) 
  Delivery type (base=none) 
0.336 -0.721 (-2.199-0.758) NVD 
0.866 0.118 (-1.499-1.264) C/S 
Dependent variable: Pain during                
 
Table 6. Results of the linear regression in investigating of the effect of HBB on pain after HSG in the presence of demographic and clinical variables 
p B (95% CI) Parameters 
   
0.023 3.560 (0.508-6.611) Intercept 
0.436 -0.437 (-1.546-0.672) Study groups (base=without Hyoscine) 
0.396 -0.047 (-0.155-0.062) Age 
0.966 0.000 (-0.018-0.017) Infertility time 
0.272 1.042 (-0.832-2.916) PID history (base=no) 
0.753 -0.190 (-1.389-1.008) Dysparonia (base=no)  
0.228 0.670 (-0.426-1.765) Dysmenorrhea (base=no) 
  Delivery type (base=none) 
0.403 -0.638 (-2.147-0.871) NVD 
0.850 -0.134 (-1.544-1.276) C/S 
Dependent variable: Pain after                
Table 7. The side effects of HSG in the HBB and the control groups   
Side effects Hyoscine-N-butyl bromide group (n=50) Control group (n=50) p † 
  
n (%) n (%) 
Nausea 8 (16 ) 7 (14)  
 
 
 
0.52  
Vomiting 0 (0) 0 (0) 
Sweating 2 (4) 4 (8) 
Dizziness 11(22) 12 (24) 
Bradycardia 0 (0) 0 (0) 
Hypotension 4 (8) 3 (6) 
† Chi-Square 
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discharged from the clinic 30-45 minutes after the proce-
dure was completed.  
 
Discussion 
This study was designed to assess the efficacy of intra-
muscular HBB on decreasing pain during and after the 
performance of HSG and also to evaluate relief of fallopi-
an tube spasm during HSG.  
The results indicated that there is no significant differ-
ence in pain scores between two groups; therefore, there is 
no advantage in using intramuscular HBB in the relief of 
pain at the point of dye injection and 30 minutes after 
HSG. This technique is quite simple, less invasive and 
provides reliable information at less cost (3, 18). Pain is 
the most common side effect of HSG and the majority of 
women believe that this diagnostic tool is painful (19). 
Abbas et al. (2017) found that administration of 20 mg 
oral HBB 30 minutes before HSG has no advantage in 
reducing the pain during and 30 minutes after the proce-
dure (2). Also, other studies showed that there is no bene-
fit in administering 10 mg oral HBB for prevention of 
pain occurring from sonohysterography (12, 20).  
Results of this study showed that the pain score at the 
point of dye injection is higher than 30 minutes after the 
procedure in both groups. Results of other studies also 
indicated that injection of the dye into the uterine cavity 
was the most painful part of the HSG procedure (2, 18, 
19). The feeling of pain peaks at the time of uterine 
distension due to contrast media injection, especially if 
there is peritoneal irritation as a result of contrast spillage 
into the peritoneal cavity (18). Use of new methods for 
contrast injection may allow an injection of a smaller 
amount of contrast media, preventing spillage of the 
medium into the peritoneal cavity, and therefore probably 
decreasing the intensity of pain (21).  
The findings of this study showed that there was no sta-
tistically significant difference in tubal spasm during HSG 
between the two groups; so there is no benefit in using 
intramuscular HBB in the prevention of spasm during 
HSG.  Very few researches have been performed about 
the effect of HBB on Fallopian tube spasm during HSG. 
However, results of one study suggested that administra-
tion of 20 mg intravenous HBB appears to be a safe and 
effective drug for relief of tubal spasm (15). Therefore, it 
seems that the injection method of HBB influences its 
effect on fallopian tubes spasm.  
In the present study, dizziness and nausea were the most 
reported side effects of HSG in both groups. Abbas et al. 
(2017) reported that nausea and dizziness are the most 
common side effects of HSG procedure in patients admin-
istered HBB (2).  
This research had some limitations. Firstly, because 
there is currently no other objective parameter to evaluate 
pain, the basic limitation of this study is that reporting 
pain via Numeric Analog Scale is a subjective process. 
Second is that pain measurements are performed only at 
two points; immediately after the dye injection and 30 
minutes after the procedure. Similar studies are needed to 
evaluate and compare the severity of pain during other 
stages of HSG. Also, another limitation of this research 
was that no baseline (pre-HSG) pain scores were meas-
ured. 
In the present study, administrating 20 mg HBB intra-
muscularly did not significantly reduce pain in patients 
undergoing HSG. Therefore, intervention studies to test 
the efficacy of intravenous HBB in pain relief during the 
HSG procedure must be performed. 
 
Conclusion 
We found that the use of intramuscular HBB, 30 
minutes before HSG, has no effect in alleviating tubal 
spasm and pain relief during and 30 minutes after the 
HSG. Therefore, we don’t recommend intramuscular HBB 
usage before the HSG to reduce tubal spasm and to pro-
vide pain relief. 
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